Journals / Erciyes Tıp Dergisi / 2011 / Cilt: 33 - Sayı: 1

The effects of flumazenile and naloxone on antinociception of dexmedetomidine

Deksmedetomidin ile sağlanan antinosisepsiyon üzerine flumazenil ve naloksonun etkisi

Pages
1–6
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We could not find any effect of flumazenil and naloxane on antinociceptive effect of dexmedetomidine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to search the effects of flumazenil and naloxane, which are frequently used in intensive care units for benzodiazepine and opioid antagonism, on dexmedetomidine’s antinociceptive effect.
📊
Key Findings & Data:Material and Methods: 50 Bulb-C albino mice, weight between 25-35 grams, were used in the study.
💡
Conclusion & Impact:Conclusion: We could not find any effect of flumazenil and naloxane on antinociceptive effect of dexmedetomidine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study was to search the effects of flumazenil and naloxane, which are frequently used in intensive care units for benzodiazepine and opioid antagonism, on dexmedetomidine’s antinociceptive effect. Material and Methods: 50 Bulb-C albino mice, weight between 25-35 grams, were used in the study. Mice were randomized in to 5 groups (n=10). Serum physiologic, 200 mg/kg of dexmedetomidine, 1 mg/kg of yohimbine + 200 mg/kg of dexmedetomidine, 1 mg/kg of flumazenil + 200 mg/kg of dexmedetomidine or 2 mg/kg of naloxone + 200 mg/kg of dexmedetomidine were applied to each mouse in every group. Although no significant analgesic effect was observed in 20., 40., 60., and 80. minutes in control group and yohimbine + dexmedetomidine group, the analgesic effects of drugs; applied to other groups were observed. The accompanying application of dexmedetomidine and yohimbine abolished its analgesic effect of dexmedetomidine, however, there were no statistical difference when compared to groups which dexmedetomidine is applied with flumazenil and naloxone. Conclusion: We could not find any effect of flumazenil and naloxane on antinociceptive effect of dexmedetomidine.

Özet

Amaç: Bu çalışmanın amacı; yoğun bakım ünitelerinde sıkça kullanılan benzodiazepin ve opioidlerin etkilerini antagonize eden flumazenil ve naloksonun, deksmedetomidinin antinosiseptif etkisi üzerine etkileþimini araþtırmaktır. Gereç ve Yöntemler: Çalışmada, ağırlığı 25-35 gram olan 50 adet Bulb-C türü albino fare kullanıldı. Denekler beş gruba ayrıldı (n=10). Her bir gruptaki fareye serum fizyolojik, 200 mg/kg deksmedetomidin, 1 mg/kg yohimbin + 200 mg/kg deksmedetomidin, 1 mg/kg flumazenil + 200 mg/kg deksmedetomidin veya 2 mg/kg nalokson + 200 mg/kg deksmedetomidin uygulandı. Bulgular: Kontrol grubu ve yohimbin + deksmedetomidin uygulanan gruplarda 20nci, 40ncı, 60ncı ve 80nci dakikalarda anlamlı analjezik etki gözlenmezken diğer gruplarda uygulanan maddelerin analjezik etkisi saptandı. Deksmedetomidin yohimbin ile beraber uygulanması onun aneljezik etkisini ortadan kaldırdı ama flumazenil veya nalokson ile birlikte uygulanan grupla arasında istatistiksel olarak fark yoktu. Sonuç: Deksmedetomidinin antinosiseptif etkisi üzerine flumazenil ve naloksonun herhangi bir etkisi bulunamamıştır.

🔖

Cite This Article

BİÇER, C., MADENOĞLU, H., AKSU, R., ESKİTAŞÇIOĞLU, E., BOYACI, A. (2022). The effects of flumazenile and naloxone on antinociception of dexmedetomidine. Erciyes Tıp Dergisi, Cilt: 33 - Sayı: 1, 1–6. https://ajindex.com/articles/502533

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Peden CJ, Prys-Roberts C. Dexmedetomidine- A powerful new adjunct to anaesthesia? Br J Anaesth 1992;68:123-125. 2.Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59: 263-268. 3. Yanıçoğlu LP. Somatik duyular: Ağrı, başağrısı ve termal duyular. In: Çavuşoğlu H, editorler. Tıbbi Fizyoloji (Guyton AC, Hall JE. Medical Physiology, Çeviri, 9. Baskı) Ankara: Nobel Tıp Kitabevi; 1996. s:609-620. 4.Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Anaesthesia 1999;54:146-165. 5.Salonen M, Reid K, Maze M. Synergistic interaction between á2 adrenergic agonists and benzodiazepines in rats. Anesthesiology 1992; 76:1004-1011. 6.Davies MF, Haimor F, Lighthall G, Clark JD. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg 2003;96:195-200. 7.Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989;71:75-79. 8.Maze M, Tranquili W. Alpha-2 Adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991;74: 581-605. 9.Kamibayashi T, Maze M. Clinical uses of a2- adrenergic agonists. Anesthesiology 2000; 93:1345-1349. 10.Kunchandy J, Kulkarni SK. Naloxone-sensitive and GABAA receptor mediated analgesic response of benzodiazepines in mice. Methods Find Exp Clin Pharmacol 1987; 9:95-99. 11.Sierralta F, Miranda HF. Analgesic effect of benzodiazepines and flumazenil. Gen.Pharmac. 1992;23:739-742. 12.Davidovich S, Niv D, Geller E, Urca G. Ro 15-1788 produces naloxone-reversible analgesia in the rat. Eur J Pharmacol 1988;146:175-179. 13.Morgan MM, Levin ED, Liebeskind JC. Characterization of the analgesic effects of the benzodiazepine antagonist, Ro 15-1788. Brain Res 1987;415:367-370. 14.Kubota K, Sugaya K, Matsuda I, Matsuoka Y, Terawaki Y. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodizepine antagonist, Ro 15- 1788. Jpn J Pharmacol 1985; 37:101-105. 15.Lee C, Rodgers RJ. Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice. Neuropharmacology 1991; 30:1263-1267. 16.Guo TZ, Davies MF, Kingery WS, Patterson AJ, Limbird LE, Maze M. Nitrous oxide produces antinociceptive response via a2B and/or a2C adrenoceptor subtypes in mice. Anesthesiology 1999;90:470-476. 17.Aantaa R, Scheinin M. Alpha 2-adrenergic agents in anaesthesia. Acta Anaesthesiol Scand 1993;37